{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:15:45Z","timestamp":1792880145742,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.metabol.2013.08.008","type":"journal-article","created":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T09:45:23Z","timestamp":1379324723000},"page":"1858-1866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients"],"prefix":"10.1016","volume":"62","author":[{"given":"Yue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-bao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6116","key":"10.1016\/j.metabol.2013.08.008_bb0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.1230721","article-title":"Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis","volume":"339","author":"Odegaard","year":"2013","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.metabol.2013.08.008_bb0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1301\/nr.2003.dec.397-412","article-title":"Evaluation of insulin sensitivity in clinical practice and in research settings","volume":"61","author":"Monzillo","year":"2003","journal-title":"Nutr Rev"},{"issue":"9","key":"10.1016\/j.metabol.2013.08.008_bb0015","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2337\/dc09-0258","article-title":"Metformin for obesity in children and adolescents: a systematic review","volume":"32","author":"Park","year":"2009","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.metabol.2013.08.008_bb0020","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2337\/diacare.22.9.1568","article-title":"Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes","volume":"22","author":"Scheen","year":"1999","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.metabol.2013.08.008_bb0025","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.metabol.2013.08.008_bb0030","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1586\/erc.11.155","article-title":"Nifedipine and telmisartan for the treatment of hypertension: the TALENT study","volume":"9","author":"Derosa","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"17","key":"10.1016\/j.metabol.2013.08.008_bb0035","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-alpha activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"issue":"1\u20133","key":"10.1016\/j.metabol.2013.08.008_bb0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejphar.2012.11.022","article-title":"Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice","volume":"698","author":"Ushijima","year":"2013","journal-title":"Eur J Pharmacol"},{"issue":"9426","key":"10.1016\/j.metabol.2013.08.008_bb0045","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.metabol.2013.08.008_bb0050","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/hr.2010.38","article-title":"Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial","volume":"33","author":"Nakao","year":"2010","journal-title":"Hypertens Res"},{"issue":"6","key":"10.1016\/j.metabol.2013.08.008_bb0055","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2013.08.008_bb0060","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/diacare.28.suppl_1.S4","article-title":"Standards of medical care in diabetes","volume":"28","author":"American Diabetes Association","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2013.08.008_bb0065","author":"Higgins"},{"issue":"1","key":"10.1016\/j.metabol.2013.08.008_bb0070","first-page":"41","article-title":"Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE","volume":"94","author":"Wong","year":"2006","journal-title":"J Med Libr Assoc"},{"issue":"7109","key":"10.1016\/j.metabol.2013.08.008_bb0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.metabol.2013.08.008_bb0080","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"11","key":"10.1016\/j.metabol.2013.08.008_bb0085","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.jhh.1002087","article-title":"Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors","volume":"20","author":"Aksnes","year":"2006","journal-title":"J Hum Hypertens"},{"issue":"3","key":"10.1016\/j.metabol.2013.08.008_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1291\/hypres.28.209","article-title":"Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients","volume":"28","author":"Fogari","year":"2005","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/j.metabol.2013.08.008_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1291\/hypres.31.615","article-title":"Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy","volume":"31","author":"Hinoi","year":"2008","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.metabol.2013.08.008_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diabres.2011.05.039","article-title":"The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance","volume":"94","author":"Lan","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1016\/j.metabol.2013.08.008_bb0105","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1291\/hypres.31.1611","article-title":"Losartan elevates the serum high-molecular weight-adiponectin isoform and concurrently improves insulin sensitivity in patients with impaired glucose metabolism","volume":"31","author":"Nishimura","year":"2008","journal-title":"Hypertens Res"},{"issue":"11","key":"10.1016\/j.metabol.2013.08.008_bb0110","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1097\/01.ASN.0000133698.80390.37","article-title":"The relationship between hyperinsulinemia, hypertension and progressive renal disease","volume":"15","author":"El-Atat","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.metabol.2013.08.008_bb0115","doi-asserted-by":"crossref","first-page":"E353","DOI":"10.1152\/ajpendo.00402.2004","article-title":"Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression","volume":"288","author":"Blendea","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.metabol.2013.08.008_bb0120","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/diabetes.51.6.1699","article-title":"Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors","volume":"51","author":"Janke","year":"2002","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.metabol.2013.08.008_bb0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2796.1998.00427.x","article-title":"Insulin resistance may or may not play a role in blood pressure regulation","volume":"244","author":"Reaven","year":"1998","journal-title":"J Intern Med"},{"issue":"9841","key":"10.1016\/j.metabol.2013.08.008_bb0130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: the bad companions","volume":"380","author":"Ferrannini","year":"2012","journal-title":"Lancet"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513002576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049513002576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:02:17Z","timestamp":1758427337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049513002576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0026049513002576"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2013.08.008","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2013.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}